CD44 and ovarian carcinoma: In the case of miR122A2, a study published in 2010 showed that it forms a unique cluster with miR214 in epithelial ovarian cancer cells (Type II/CD44-) that was responsible for the regulation of the pro-inflammatory NF-kB pathway and the AKT survival pathway [38].